Resolvis Omega

Resolvis (specifically Resolvis Omega) is an ophthalmic emulsion developed by Medivis for the treatment of dry eye disease and other ocular surface conditions. The formulation contains omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are designed to integrate into and stabilize the lipid layer of the tear film. This action reduces tear evaporation and provides a protective barrier on the ocular surface. Additionally, these omega-3 fatty acids serve as precursors to specialized pro-resolving mediators (SPMs) like resolvins, which help modulate the inflammatory response associated with chronic dry eye. The product is typically administered as topical eye drops and is often regulated as a medical device in European markets.

Brand names

ResolvisResolvis Omega